Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD) A PRISMA-compliant systematic review and network meta-analysis

被引:54
作者
Sawangjit, Ratree [1 ,2 ]
Chongmelaxme, Bunchai [3 ]
Phisalprapa, Pochamana [4 ]
Saokaew, Surasak [2 ,3 ,5 ]
Thakkinstian, Ammarin [6 ]
Kowdley, Kris V. [7 ]
Chaiyakunapruk, Nathorn [2 ,3 ,8 ,9 ]
机构
[1] Mahasarakham Univ, Dept Clin Pharm, CPRU, Fac Pharm, Maha Sarakham, Thailand
[2] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Bandar Sunway 46150, Selangor, Malaysia
[3] Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Phitsanulok, Thailand
[4] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok, Thailand
[5] Univ Phayao, Sch Pharmaceut Sci, Ctr Hlth Outcome Res & Therapeut Safety, Phayao, Thailand
[6] Mahidol Univ, Ramathibodi Hosp, Sect Clin Epidemiol & Biostat, Fac Med, Bangkok, Thailand
[7] Swedish Med Ctr, Liver Care Network & Organ Care Res, Seattle, WA USA
[8] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA
[9] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
关键词
fibrosis; GRADE; histological outcome; NAFLD; NASH; network meta-analysis; PLACEBO-CONTROLLED TRIAL; INSULIN-SENSITIZING AGENTS; VITAMIN-E SUPPLEMENTATION; DOUBLE-BLIND; URSODEOXYCHOLIC ACID; CLINICAL-TRIAL; AMERICAN ASSOCIATION; RANDOMIZED-TRIALS; STEATOHEPATITIS; PIOGLITAZONE;
D O I
10.1097/MD.0000000000004529
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The prevalence of nonalcoholic fatty liver disease (NAFLD) has significantly increased over the last decades. Despite existence of several interventions, there remains unclear which interventions work the best. Methods: A systematic review and network meta-analysis of randomized trials comparing efficacy of all treatment options in NAFLD were performed to determine comparative efficacy and safety of interventions in the management of NAFLD. Several electronic databases were searched up to Nov 15, 2015. Outcomes include liver histological outcomes (i.e., fibrosis), all-cause mortality, cirrhosis, and safety. A network meta-analysis was applied to estimate pooled risk ratios (RR). Quality of evidence was assessed using GRADE criteria. Results: A total of 44 studies (n = 3802) were eligible. When compared with placebo, obeticholic acid (OCA) was the only intervention that significantly improved fibrosis with RR (95% CI) of 1.91 (1.15, 3.16), while pentoxyfylline (PTX) demonstrated improved fibrosis without statistical significance with RR (95% CI) of 2.27 (0.81, 6.36). Only thiazolidinedione (TZD) and vitamin E use resulted in significant increase in resolution of NASH, while OCA, TZD, and vitamin E significantly improved other outcomes including NAS, steatosis, ballooning, and inflammation outcomes. Quality of evidence varied from very low (i.e., metformin, PTX on mean change of ballooning grade) to high (OCA, TZD, vitamin E on improving histological outcomes). Limitations of this study were lack of relevant long-term outcomes (e.g., cirrhosis, death, safety), possible small study effect, and few head-to-head studies. Conclusions: Our study suggests potential efficacy of OCA, TZD, and vitamin E in improving histologic endpoints in NAFLD. These findings are however based on a small number of studies. Additional studies are awaited to strengthen this network meta-analysis.
引用
收藏
页数:15
相关论文
共 81 条
  • [1] Betaine for Nonalcoholic Fatty Liver Disease: Results of a Randomized Placebo-Controlled Trial
    Abdelmalek, Manal F.
    Sanderson, Schuyler O.
    Angulo, Paul
    Soldevila-Pico, Consuelo
    Liu, Chen
    Peter, Joy
    Keach, Jill
    Cave, Matt
    Chen, Theresa
    McClain, Craig J.
    Lindor, Keith D.
    [J]. HEPATOLOGY, 2009, 50 (06) : 1818 - 1826
  • [2] Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
    Ahmed, Aijaz
    Wong, Robert J.
    Harrison, Stephen A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (12) : 2062 - 2070
  • [3] Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
    Aithal, Guruprasad P.
    Thomas, James A.
    Kaye, Philip V.
    Lawson, Adam
    Ryder, Stephen D.
    Spendlove, Ian
    Austin, Andrew S.
    Freeman, Jan G.
    Morgan, Linda
    Weeber, Jonathan
    [J]. GASTROENTEROLOGY, 2008, 135 (04) : 1176 - 1184
  • [4] Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
    Argo, Curtis K.
    Patrie, James T.
    Lackner, Carolin
    Henry, Thomas D.
    de lange, Eduard E.
    Weltman, Arthur L.
    Shah, Neeral L.
    Al-Osaimi, Abdullah M.
    Pramoonjago, Patcharin
    Jayakumar, Saumya
    Binder, Lukas P.
    Simmons-Egolf, Winsor D.
    Burks, Sandra G.
    Bao, Yongde
    Taylor, Ann Gill
    Rodriguez, Jessica
    Caldwell, Stephen H.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 (01) : 190 - 197
  • [5] GRADE guidelines: 3. Rating the quality of evidence
    Balshem, Howard
    Helfand, Mark
    Schuenemann, Holger J.
    Oxman, Andrew D.
    Kunz, Regina
    Brozek, Jan
    Vist, Gunn E.
    Falck-Ytter, Yngve
    Meerpohl, Joerg
    Norris, Susan
    Guyatt, Gordon H.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) : 401 - 406
  • [6] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    Belfort, Renata
    Harrison, Stephen A.
    Brown, Kenneth
    Darland, Celia
    Finch, Joan
    Hardies, Jean
    Balas, Bogdan
    Gastaldelli, Amalia
    Tio, Fermin
    Pulcini, Joseph
    Berria, Rachele
    Ma, Jennie Z.
    Dwivedi, Sunil
    Havranek, Russell
    Fincke, Chris
    DeFronzo, Ralph
    Bannayan, George A.
    Schenker, Steven
    Cusi, Kenneth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) : 2297 - 2307
  • [7] Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality
    Berry, Donold
    Wathen, J. Kyle
    Newell, Margaret
    [J]. CLINICAL TRIALS, 2009, 6 (01) : 28 - 41
  • [8] Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis
    Bjelakovic, Goran
    Nikolova, Dimitrinka
    Gluud, Lise Lotte
    Simonetti, Rosa G.
    Gluud, Christian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08): : 842 - 857
  • [9] Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
    Boettcher, E.
    Csako, G.
    Pucino, F.
    Wesley, R.
    Loomba, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (01) : 66 - 75
  • [10] Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x